EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

P2RY6+ tumor-associated macrophages as a therapeutic target: suppressing tumor growth and enhancing chemosensitivity in triple-negative breast cancer

Xin Wang, Mingyue Ma, Mingyu Zhang, Han Lu, Ying Liu, Yang Zhou, Bing Han

Cellular Oncology · 06.06.2026 · 49 (4)

DOI: 10.1007/s13402-026-01239-w ↗

Kurz gefasst

Fachartikel in der Zeitschrift Cellular Oncology, online erschienen am 06.06.2026. Verfasst von Xin Wang und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Breast Surgery, General Surgery Center, The First Hospital of Jilin University, Changchun City, Jilin Province, 130021, P.R. China. Hauptthemen laut MEDLINE: Triple Negative Breast Neoplasms, Tumor-Associated Macrophages, Receptors, Purinergic P2, Drug Resistance, Neoplasm. Die Arbeit nennt 53 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Triple Negative Breast NeoplasmsTumor-Associated MacrophagesReceptors, Purinergic P2Drug Resistance, NeoplasmMolecular Targeted TherapyHumansAnimalsFemaleCell Line, TumorCell ProliferationCalgranulin BSignal TransductionMiceTumor MicroenvironmentNF-kappa BToll-Like Receptor 4

Stichwörter der Autor:innen

Cancer neuroscienceMacrophage polarizationPurinergic receptorsTumor immunity

Substanzen

Receptors, Purinergic P2purinoceptor P2Y6Calgranulin BNF-kappa BToll-Like Receptor 4

Autor:innen und Institutionen

  • Department of Breast Surgery, General Surgery Center, The First Hospital of Jilin University, Changchun City, Jilin Province, 130021, P.R. China.
  • Department of Breast Surgery, General Surgery Center, The First Hospital of Jilin University, Changchun City, Jilin Province, 130021, P.R. China. han_bing@jlu.edu.cn.

Zitieren

APA

Wang, X., Ma, M., Zhang, M., Lu, H., Liu, Y., Zhou, Y., & Han, B. (2026). P2RY6+ tumor-associated macrophages as a therapeutic target: suppressing tumor growth and enhancing chemosensitivity in triple-negative breast cancer. Cellular Oncology, 49(4). https://doi.org/10.1007/s13402-026-01239-w

Vancouver

Wang X, Ma M, Zhang M, Lu H, Liu Y, Zhou Y, et al. P2RY6+ tumor-associated macrophages as a therapeutic target: suppressing tumor growth and enhancing chemosensitivity in triple-negative breast cancer. Cellular Oncology. 2026;49(4). doi:10.1007/s13402-026-01239-w

BibTeX
@article{Wang2026,
  author = {Wang, Xin and Ma, Mingyue and Zhang, Mingyu and Lu, Han and Liu, Ying and Zhou, Yang and Han, Bing},
  title = {P2RY6+ tumor-associated macrophages as a therapeutic target: suppressing tumor growth and enhancing chemosensitivity in triple-negative breast cancer},
  journal = {Cellular Oncology},
  year = {2026},
  volume = {49},
  number = {4},
  doi = {10.1007/s13402-026-01239-w}
}
Kostenlos starten →